Patents by Inventor Hardev Pandha

Hardev Pandha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR THE TREATMENT OF BLADDER CANCER
    Publication number: 20190134120
    Abstract: The present invention relates to methods of treating bladder cancer with human enterovirus C (HEC) in combination with chemotherapy or radiation therapy. The present invention also relates to methods for increasing susceptibility of a cancer cell to infection by HEC.
    Type: Application
    Filed: August 3, 2018
    Publication date: May 9, 2019
    Inventors: DARREN SHAFREN, Gough Au, Hardev Pandha, Guy Simpson
  • Methods for diagnosing cancer
    Patent number: 9624548
    Abstract: Described are bladder cancer specific biomarkers and lung cancer specific biomarkers comprising the nucleic acid sequence of the Engrailed-2 (EN2) gene or the amino acid sequence of the encoded EN2 protein. Also described are uses of the biomarkers in the treatment, diagnosis, monitoring and imaging of bladder cancer and lung cancer.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: April 18, 2017
    Assignee: The University of Surrey
    Inventors: Richard Morgan, Hardev Pandha
  • METHODS FOR THE TREATMENT OF BLADDER CANCER
    Publication number: 20160136211
    Abstract: The present invention relates to methods of treating bladder cancer with human enterovirus C (HEC) in combination with chemotherapy or radiation therapy. The present invention also relates to methods for increasing susceptibility of a cancer cell to infection by HEC.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 19, 2016
    Inventors: Darren Raymond Shafren, Gough AU, Hardev Pandha, Guy Simpson
  • ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY
    Publication number: 20130243732
    Abstract: Provided herein are methods for treating a proliferative disorder in a subject comprising administering to the subject one or more reoviruses and one or more agents that modulate expression or activity of pro-inflammatory cytokines. For example, the agents may inhibit expression or activity of pro-inflammatory cytokines.
    Type: Application
    Filed: May 21, 2013
    Publication date: September 19, 2013
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Bradley G. Thompson, Hardev Pandha
  • Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
    Patent number: 8470312
    Abstract: Provided herein are methods for treating a proliferative disorder in a subject comprising administering to the subject one or more reoviruses and one or more agents that modulate expression or activity of pro-inflammatory cytokines. For example, the agents may inhibit expression or activity of pro-inflammatory cytokines.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: June 25, 2013
    Assignee: Oncolytics Biotech, Inc.
    Inventors: Matthew C. Coffey, Bradley G. Thompson, Hardev Pandha
  • Cancer biomarkers
    Patent number: 8460882
    Abstract: Provided is a biomarker for detecting cancer, in particular prostate cancer in a male subject, the biomarker comprising at least one homeodomain containing transcription factor, such as a HOX peptide or EN-2 peptide, or a fragment thereof. The use of said biomarker in detecting and/or treating prostate cancer is provided, together with methods and kits therefor.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: June 11, 2013
    Assignee: The University of Surrey
    Inventors: Hardev Pandha, Richard George Leonard Morgan
  • MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTION
    Publication number: 20110086005
    Abstract: Provided herein are methods of treating a proliferative disorder in a subject comprising decreasing interstitial pressure and/or increasing vascular permeability in the subject and administering to the subject an oncolytic virus. Such methods improve oncolytic viral delivery and distribution.
    Type: Application
    Filed: May 27, 2009
    Publication date: April 14, 2011
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Bradley G. Thompson, Hardev Pandha
  • ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY
    Publication number: 20110070200
    Abstract: Provided herein are methods for treating a proliferative disorder in a subject comprising administering to the subject one or more reoviruses and one or more agents that modulate expression or activity of pro-inflammatory cytokines. For example, the agents may inhibit expression or activity of pro-inflammatory cytokines.
    Type: Application
    Filed: May 27, 2009
    Publication date: March 24, 2011
    Applicant: ONCOLYTICS BIOTECH INC.
    Inventors: Matthew C. Coffey, Bradley G. Thompson, Hardev Pandha
  • CANCER BIOMARKERS
    Publication number: 20100093558
    Abstract: Provided is a biomarker for detecting cancer, in particular prostate cancer in a male subject, the biomarker comprising at least one homeodomain containing transcription factor, such as a HOX peptide or EN-2 peptide, or a fragment thereof. The use of said biomarker in detecting and/or treating prostate cancer is provided, together with methods and kits therefor.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 15, 2010
    Applicant: THE UNIVERSITY OF SURREY
    Inventors: Hardev Pandha, Richard George Leonard Morgan